Cargando…

Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency

Detalles Bibliográficos
Autores principales: Küpper, Clemens, Heinrich, Johanna, Kamm, Katharina, Bücklein, Veit, Rothenfusser, Simon, Straube, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807970/
https://www.ncbi.nlm.nih.gov/pubmed/31597693
http://dx.doi.org/10.1212/NXI.0000000000000628
_version_ 1783461731489546240
author Küpper, Clemens
Heinrich, Johanna
Kamm, Katharina
Bücklein, Veit
Rothenfusser, Simon
Straube, Andreas
author_facet Küpper, Clemens
Heinrich, Johanna
Kamm, Katharina
Bücklein, Veit
Rothenfusser, Simon
Straube, Andreas
author_sort Küpper, Clemens
collection PubMed
description
format Online
Article
Text
id pubmed-6807970
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-68079702019-12-13 Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency Küpper, Clemens Heinrich, Johanna Kamm, Katharina Bücklein, Veit Rothenfusser, Simon Straube, Andreas Neurol Neuroimmunol Neuroinflamm Clinical/Scientific Notes Lippincott Williams & Wilkins 2019-10-09 /pmc/articles/PMC6807970/ /pubmed/31597693 http://dx.doi.org/10.1212/NXI.0000000000000628 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Clinical/Scientific Notes
Küpper, Clemens
Heinrich, Johanna
Kamm, Katharina
Bücklein, Veit
Rothenfusser, Simon
Straube, Andreas
Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title_full Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title_fullStr Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title_full_unstemmed Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title_short Pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
title_sort pembrolizumab for progressive multifocal leukoencephalopathy due to primary immunodeficiency
topic Clinical/Scientific Notes
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6807970/
https://www.ncbi.nlm.nih.gov/pubmed/31597693
http://dx.doi.org/10.1212/NXI.0000000000000628
work_keys_str_mv AT kupperclemens pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency
AT heinrichjohanna pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency
AT kammkatharina pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency
AT buckleinveit pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency
AT rothenfussersimon pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency
AT straubeandreas pembrolizumabforprogressivemultifocalleukoencephalopathyduetoprimaryimmunodeficiency